ARCHIVES

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

This article is from The Cancer Letter archive.

Vol. 10 No. 48 | December 13, 1984

Download PDF Visit The Full Archive

Related Articles

Komen Brand Takes Hit After PR Disaster

March 30, 2012

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.

February 25, 2000

NTP Release Third Report On Carcinogens

January 13, 1984

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

Uncertainty Lingers After NCI Meeting With Army; Activists Offer Advice

November 6, 1992